Contact this trialFirst, we need to learn more about you.
Cannabinoid
Cannabidiol for PTSD
Recruiting0 awardsPhase 2
New York, New York
This trial will test whether cannabidiol (CBD) can help relieve symptoms of post-traumatic stress disorder (PTSD). Half of the 120 subjects will also have mild traumatic brain injury (TBI). The trial will last 8 weeks, and subjects will be given either 400 or 800 mg of CBD per day, or a placebo. The primary outcome will be change in PTSD symptoms as measured by change in the Clinician-Administered PTSD Scale (CAPS-5) total score.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.